A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
Zuojun Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Alex Zhavoronkov(Hong Kong Science and Technology Parks Corporation), Fengming Luo(Sichuan University), Dedong Ma(Qilu Hospital of Shandong University), David Gennert(Insilicos (United States)), Ying Meng(Nanfang Hospital), Sang Liu, Haohui Fang(Anhui Provincial Hospital), Zuke Xiao(Jiangxi Provincial People's Hospital), Mikhail Korzinkin(Insilico Medicine (United States)), Ping Wang(Guangzhou Women and Children Medical Center), Shan Chen(Insilico Biotechnology (Germany)), Li Zhao(Children's National), Huiping Li, Jie Cao(Jiangsu University), Jinghong Dai(Nanjing Drum Tower Hospital), Yuan Lv(Insilico Biotechnology (Germany)), Yipeng Ding(Hainan General Hospital), Feng Ren(Unknown), Sujata Rao(Insilicos (United States)), Chunting Tan(University of California San Diego), Carol Satler(Insilicos (United States)), Hui Cui(Insilico Biotechnology (Germany)), Pingchao Xiang(Peking University Shougang Hospital), Heng Zhao, Hong Liu(Zhejiang Chinese Medical University), Pinhua Pan(Central South University)
Cited by 92
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|504
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
|Aging|2016|377
The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage
|Frontiers in Immunology|2023|335
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
Validation of biomarkers of aging
|Nature Medicine|2024|299